Healthcare use trajectories and costs for people in the last year of life: a retrospective analysis using linked primary care and hospital data in England by Luta, Xhyljeta et al.
 
 
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Healthcare use trajectories and costs for people in the last year
of life: a retrospective analysis using linked primary care and
hospital data in England
Citation for published version:
Luta, X, Diernberger, K, Bowden, J, Droney, J, Howdon, D, Schmidlin, K, Rodwin, V, Hall, PS & Marti, J
2020, 'Healthcare use trajectories and costs for people in the last year of life: a retrospective analysis using
linked primary care and hospital data in England', BMJ Supportive & Palliative Care.
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
BMJ Supportive & Palliative Care
Publisher Rights Statement:
This is an open access article distributed in
accordance with the Creative Commons Attribution Non
Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided the original work is properly cited,
appropriate credit is given, any changes made indicated, and the use is non-commercial.See: http://
creativecommons. org/ licenses/ by- nc/ 4.
0/.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 04. Jan. 2021
1Luta X, et al. BMJ Supportive & Palliative Care 2020;0:1–9. doi:10.1136/bmjspcare-2020-002630
Healthcare trajectories and costs in 
the last year of life: a retrospective 
primary care and hospital analysis
Xhyljeta Luta   ,1,2 Katharina Diernberger   ,3,4 Joanna Bowden,4,5 
Joanne Droney,6 Daniel Howdon   ,7 Kurt Schmidlin,8 Victor Rodwin,9,10 
Peter Hall,11 Joachim Marti2,10
To cite: Luta X, 
Diernberger K, Bowden J, 
et al. BMJ Supportive & 
Palliative Care Epub ahead 
of print: [please include Day 
Month Year]. doi:10.1136/
bmjspcare-2020-002630
 ► Additional material is 
published online only. To view 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
bmjspcare- 2020- 002630).
For numbered affiliations see end 
of article.
Correspondence to
Dr Xhyljeta Luta, Centre for 
Primary Care and Public 
Health (Unisanté), University 
of Lausanne, Lausanne 1015, 
Switzerland;  
 xhyljeta. luta@ unisante. ch
Received 8 August 2020
Revised 15 October 2020
Accepted 5 November 2020
Original research
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Objectives To analyse healthcare utilisation 
and costs in the last year of life in England, and 
to study variation by cause of death, region of 
patient residence and socioeconomic status.
Methods This is a retrospective cohort study. 
Individuals aged 60 years and over (N=108 510) 
who died in England between 2010 and 2017 
were included in the study.
Results Healthcare utilisation and costs in 
the last year of life increased with proximity 
to death, particularly in the last month of 
life. The mean total costs were higher among 
males (£8089) compared with females (£6898) 
and declined with age at death (£9164 at age 
60–69 to £5228 at age 90+) with inpatient care 
accounting for over 60% of total costs. Costs 
decline with age at death (0.92, 95% CI 0.88 to 
0.95, p<0.0001 for age group 90+ compared 
with to the reference category age group 60–69) 
and were lower among females (0.91, 95% CI 
0.90 to 0.92, p<0.0001 compared with males). 
Costs were higher (1.09, 95% CI 1.01 to 1.14, 
p<0.0001) in London compared with other 
regions.
Conclusions Healthcare utilisation and costs 
in the last year of life increase with proximity to 
death, particularly in the last month of life. Finer 
geographical data and information on healthcare 
supply would allow further investigating whether 
people receiving more planned care by primary 
care and or specialist palliative care towards the 
end of life require less acute care.
BACKGROUND
Around half a million people die each year 
in the England, with more than a fifth 
older than 90 years.1 While 70%–80% of 
those who die would benefit from pallia-
tive care2 over 90 000 decedents per year 
have unmet palliative care needs3 that can 
differ widely by disease and are influenced 
by the availability of appropriate care and 
patient preferences.4 5 Previous research 
has shown that many dying patients 
receive high- intensity care without clear 
evidence of benefits, often at odds with 
their known preferences.6 7 While many 
people at the end of life would prefer to 
be cared for at home, around 90%8 spend 
time in hospitals in their final year of life 
and over 50% of people die there.9
We define healthcare use trajectories 
as the sequence of interactions with the 
primary and secondary care, including 
general practitioner (GP), outpatient and 
inpatient visits. This enables patterns of 
healthcare use to be described for patient 
groups with certain characteristics. A 
more normative approach consists in 
describing the intensity of healthcare use, 
which enables the value of specific service 
use to be questioned. This is particularly 
important for palliative and end- of- life 
care where the balance between benefit 
and harm of intensive treatments can be 
questionable.
Evidence suggests that excessive inpa-
tient care could be avoided if patients were 
offered high- quality alternatives10 11 that 
provide care in line with their preferences 
while also reducing cost of care that is, on 
average, five times higher in the last year 
of life than in previous years.12 England 
has been at the forefront of palliative and 
other high quality care at the end of life.13 
However, the increasing complexity and 
heterogeneity of patient needs and pres-
sures on healthcare budgets pose consid-
erable challenges to the provision of high 
quality, equitable end- of- life care aligned 
with patient preferences.
Over the past decade, large patient- level 
datasets have become increasingly avail-
able and now allow investigators to follow 
patients along their entire care path-
ways, as they interact with primary and 
E
dinburgh. P
rotected by copyright.
 on D
ecem
ber 14, 2020 at U
niversity of
http://spcare.bm
j.com
/
B
M
J S
upport P
alliat C
are: first published as 10.1136/bm
jspcare-2020-002630 on 2 D
ecem
ber 2020. D
ow
nloaded from
 
 2 Luta X, et al. BMJ Supportive & Palliative Care 2020;0:1–9. doi:10.1136/bmjspcare-2020-002630
Original research
secondary care.14 15 These resources make it possible 
to study the heterogeneity of decedent trajectories 
in a range of care settings. To date, few studies have 
analysed utilisation of a breadth of healthcare services 
and associated costs in the last months of life in the 
UK.14 15 These studies suggest that higher healthcare 
use is associated with a range of patient characteristics 
(including age, gender and cause of death) and that 
hospital costs account for most end- of- life care costs 
all of which increase significantly with proximity to 
death and decline with age.
With two notable exceptions,9 16 these studies 
focused on cost trends and how they are affected by 
age and proximity to death. They examined neither 
variation in cost trajectories nor the intensity of care 
provided. In contrast, this study aims to analyse a 
patient- level linked dataset covering primary care, 
hospital outpatient and inpatient care and assess the 
intensity of services of people 60 years and over, 
received in the last year and last month of life and how 
these differ by cause of death, region of residence and 
socioeconomic status.
METHODS
Study design
We conducted a retrospective cohort study of people 
aged 60 years and over, who died between 2010 and 
2017. We relied on routinely collected linked data 
from a nationally representative sample of the English 
population.
Data sources
We used individual- level data linked from three 
sources: Clinical Practice Research Datalink (CPRD), 
Hospital Episode Statistics (HES) and death registra-
tions provided by the Office for National Statitics. 
CPRD is an ongoing research service providing elec-
tronic medical record data across GP practices in 
the UK, covering approximately 7% of the popula-
tion.17–19 HES provides data on secondary care use 
in England, including hospitalisations, Accident & 
Emergency (A&E) contacts, intensive care unit (ICU) 
use and outpatient care. This was supplemented with 
data from the English Index of Multiple Deprivation 
(IMD) at the level of the lower super output area of 
the patient’s residence.20 A detailed description of 
available data sources is provided in figure 1. These 
data were linked using unique patient identifiers.
Inclusion and exclusion criteria
The original sample size included 510 307 individuals. 
Of these, 289 688 met the initial inclusion criteria and 
178 176 of those who did not die during study period 
were excluded from the analysis. We therefore included 
108 510 patients aged 60 years and over at study 
inception (1 January 2010), who died during the study 
period, were registered continuously with CPRD for 
at least 12 months and met data quality requirements. 
We estimate that during the same period 2010–2017 
around 3 million deaths have occurred in England in 
the age group 60 and older, our final sample therefore 
represents 3.5% of this population of decedents. A 
detailed description of inclusion and exclusion criteria 
is provided in online supplemental file 1.
Patient characteristics
Patient characteristics included age at death (60–69, 
7079, 80–89, 90+), gender and primary cause of 
death based on International Classification of Diseases 
(ICD-10) codes (cancer, diseases of the nervous 
system, dementia and Alzheimer’s disease, chronic 
obstructive pulmonary disease (COPD), other respira-
tory diseases, heart failure, ischeamic heart diseases, 
cereberovascular disease, other circulatory diseases, 
external causes, infectious diseases and ‘other’). We 
calculated the comorbidity burden over the last 5 years 
of life, categorised into four groups (0, 1–3, 4–6, 7+) 
using the Charlson Comorbidity Index.21 In addition, 
we included the patient’s government office region 
and IMD information about the patient’s usual small 
area of residence.
Outcome measures
Inpatient care
We examined inpatient healthcare use in the last 
year of life using the following measures: number 
of hospital admissions, total length hospital stays (in 
days), number of A&E admissions, ICU admissions, 
length of ICU stay (in days) and number of supported 
organs while in ICU. The costing of inpatient hospital 
care was based on Healthcare Resource Group (HRG), 
a classification system of clinically similar admissions 
that use common levels of healthcare resources used 
for reimbursement of healthcare services.22 We used 
national schedules of reference costs (2010–2017) to 
assign a cost to each HRG. The costs are based on 
national average unit costs provided for each service.23 
We matched HRGs with reference costs for each year 
and if costs were not available on national schedules of 
reference costs, tariffs were used. For A&E, we used 
2017 reference costs.
Outpatient care
Outpatient data included information on services 
provided in the outpatient clinic setting, including the 
treatment specialty. We examined the number of outpa-
tient appointments per participant and their associated 
costs. Costs for outpatient appointments were derived 
from national schedules of reference costs, which are 
based on national average unit costs provided for each 
service (service code).
Primary care contacts
Primary care contacts were identified using the consul-
tation file, which contains information relating to the 
type of consultation entered by GPs including GP 
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consultations, out- of- hours consultations, telephone 
consultations, home consultations and day case consul-
tations. The costs were obtained from standard refer-
ence sources including the Personal Social Services 
Research Unit Costs of Health and Social Care 2015 
report.24
Prescriptions
The number and details of primary care prescrip-
tions were obtained through the therapy data set. 
We utilised prescription cost analysis (PCA), which 
provides details of the number of items, and the net 
ingredient cost of all prescriptions dispensed in the 
community in England. Prescriptions were classified 
according to their British National Formulary chapter 
subparagraph, and the mean subparagraph cost was 
attached according to the England PCA.25
Statistical analysis
We calculated means and SD for the use of each dimen-
sion of healthcare service and total cost in the last year 
and last month of life. We documented healthcare use 
by region and IMD quintile (lowest and highest IMD 
equating to most and least deprived categories, respec-
tively). Missing values of cost were imputed based on 
gender, age and cause of death. We relied on Poisson 
regression to estimate the independent effects of age, 
gender, comorbidity burden, cause of death, region 
and IMD on healthcare use (ie, hospital admissions, 
primary care contacts) and we used generalised linear 
models to study factors associated with costs, including 
interactions between age and gender, as well as age and 
cause of death. Data management and analysis were 
conducted using Stata V.15 (StataCorp).
Patient and public involvement
Patients and public were not involved in the design and 
conduct of this research.
RESULTS
Patient characteristics
Our final sample consisted of 108 510 participants 
aged 60 years and over, who died between 2010 
and 2017(table 1). The coverage of CPRD varies by 
regions, giving rise to under- representation and over- 
representation of some regions.26 The majority of 
Figure 1 Description of data sources. CPRD, Clinical Practice Research Datalink; HES, Hospital Episode Statistics; ONS, Office for 
National Statitics.
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decedents (88%) were over 75 years and 55.7% were 
female. The mean age at death was 84.6 years. The 
most common primary causes of death were circu-
latory and cardiovascular diseases (27.1%), cancer 
(23.4%), respiratory diseases including COPD (15.0%) 
and dementia (10.8%). The proportion of participants 
with 1–3 comorbidities was 39.1%
Healthcare utilisation
Figure 2 A,B shows healthcare utilisation by care 
setting. Healthcare service use increased significantly 
over the last 12 months of life, rising sharply in the 
last month of life.
Of all study participants, 78% were hospitalised at 
least once in the last year of life (table 2). Overall, the 
mean number of hospital admissions the last year of life 
was 2.4 (SD: 5.9) and 0.6 (SD: 0.9) in the last month 
of life. The mean number of hospital bed days in the 
last year life was 23.3 (SD: 31.9) and 4.7 (SD:9.1) in 
the last month of life. Younger decedents, males, those 
with more comorbidities, the most socioeconomically 
deprived and those living in London had a higher 
mean number of hospital admissions and hospital days 
in the last year and last month of life. Cancer dece-
dents had higher mean of hospital admissions in the 
last year of life, while in the last month of life deaths 
from infectious diseases were preceded by a higher 
mean of hospital admissions and hospital days (online 
supplemental files 2 and 3).
Over 74% of decedents had at least one A&E admis-
sion in the last 12 months of life and 43% in the last 
month of life. Overall, the mean number of A&E 
admissions in the last 12 months of life was 1.7 (SD: 
1.8) and 0.5 (SD: 0.6) in the last month of life. Younger 
decedents, males, with more comorbidities and those 
who were the least socioeconomically deprived and 
London region had higher number of A&E admissions 
in the last 12 months and last month of life (online 
supplemental files 2 and 3).
Among those admitted in the last year of life, they 
attended ICU on average 1.0 times (SD: 0.2) and the 
mean ICU LOS was 6.7 days (SD: 10.0). 66.8% of dece-
dents had at least one outpatient appointment in the 
last year of life. Decedents had, on average, 5.1 (SD: 
11.9) outpatient appointments in the last 12 months 
of life. Males, younger decedents, cancer deaths, those 
with more comorbidities and the most socioeconomi-
cally deprived had higher mean numbers of outpatient 
appointments in the last year and last month of life. 
(online supplemental files 2 and 3).
The majority (86.8%) of decedents had at least one 
primary care contact in the last year of life. Decedents 
had an average of 19.8 (SD: 17.6) GP consultations in 
this period and 2.8 (SD: 3.0) in the last month of life. 
Males, younger decedents, cancer deaths, those with 
more comorbidities, those in the North- East and South- 
East regions had a higher mean number of primary 
care contacts in the last 12 and last month of life. Over 
80% of decedents had at least one prescription filled 
by GP in the last 12 months. Overall, utilisation varied 
only slightly with socioeconomic deprivation (online 
supplemental files 2–5).
Table 1 Characteristics of study population
Characteristics No Per cent
Gender
  Male 48 067 44.3
  Female 60 443 55.7
Age at death
  60–69 3398 3.13
  70–79 25 863 23.83
  80–89 46 664 43.0
  90+ 32 585 30.03
Primary cause of death
  Cancer 25 406 23.4
  Other 16 770 15.5
  Dementia 11 739 10.8
  Other respiratory diseases 10 613 9.8
  Ischeamic heart diseases 12 477 11.5
  Other circulatory diseases 8492 7.8
  Cereberovascular diseases 7027 6.5
  COPD 5691 5.2
  Diseases of the nervous system* 5646 5.2
  External causes 2151 2
  Heart failure 1382 1.3
  Infectious diseases 1116 1.0
No of comorbidities†
  0 60 646 55.9
  1–3 42 394 39.1
  4–6 2885 2.7
  7+ 2585 2.4
Index of Multiple Deprivation
  First (most deprived) 23 701 21.8
  Second 24 313 22.4
  Third 24 825 22.9
  Fourth 19 568 18
  Fifth (least deprived) 16 103 14.8
Region
North East 1591 1.5
North West 16 717 15.4
Yorkshire and The Humber 2214 2.0
West Midlands 13 867 12.8
East of England 9350 8.6
South West 13 282 12.2
South Central 17 925 16.5
London 12 394 11.4
South East Coast 21 170 19.5
Total 108 510 100
*Includes mainly Alzheimer’s, Parkinson and motor neuron diseases.
†Derived from hospital data (primary diagnosis).
COPD, chronic obstructive pulmonary disease.
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Healthcare costs
Figure 2C shows total healthcare costs by cost type 
and time to death. Costs increased significantly in the 
last month of life. Online supplemental file 4 outlines 
mean total costs by age, gender, cause of death, comor-
bidity, IMD and region. Costs were higher among 
males (£8089) compared with females (£6898) and 
declined with age at death (£9164 at age 60–69 to 
£5228 at age 90+). Hospital care accounted for over 
60% of total costs. Inpatient healthcare costs by age, 
disease and time to death are shown in online supple-
mental files 6 and 7).
The mean A&E cost per decedent was £329, outpa-
tient cost £545, primary care cost £1088 and prescrip-
tion cost £764. Mean cost increased with the number 
of comorbidities (from £5431 among decedents with 
no comorbidity to £13 124 among those with 7+ 
comorbidities). Cost was higher among cancer or 
COPD deaths, the least socioeconomically deprived 
and London region.
Multivariate models
Results from the models for healthcare utilisation 
(online supplemental files 8–11) suggest that, except 
for outpatient visits, hospital admissions, primary 
care contacts and A&E visits increased sharply in 
the last month of life. The use of healthcare (particu-
larly hospital use) declined significantly with age and 
increased with the number of comorbidities.
The main drivers of costs are proximity to death and 
comorbidity burden (figure 3). Models also suggest 
that costs decline with age at death (0.92, 95% CI 
Figure 2 Healthcare utilisation and costs in the last 12 months of life. (A) Use of inpatient care. (B) Primary and hospital outpatient 
care. (C) Total costs by cost type. A&E, Accident & Emergency, GP, general practitioner.
Table 2 Healthcare utilisation in the last 12 months and in the last month of life
Healthcare utilisation Last year of life Average per month Last month of life
% with >0
  Hospital admission 78.2 – 27.9
  ICU admission 6.2 – 4.2
  A&E visit 74.7 – 43.7
  Outpatient attendance 66.8 – 2.7
  Primary care contact (any) 86.8 – 1.9
  Prescription filled by GP 84.9 – 63.1
Inpatient care 12 months
  Hospital admissions, mean (SD, IQR) 2.4 (5.9–2) 0.2 (0.4–0.2) 0.6 (0.9–1)
  Total LOS (days), mean (SD, IQR) 23.3 (31.9–32) 1.9 (2.6–2.6) 4.7 (9.1–7)
ICU (among users, n=6793)
  ICU admissions, mean (SD, IQR) 1.0 (0.2–0) 0.1 (0.0–0) 1.0 (0.2–0)
  ICU total LOS, mean (SD, IQR) 6.7 (10.0–5) 0.5 (0.8–0.4) 5.6 (6.6–5)
  No of organs supported, mean (SD, IQR) 1.9 (1.1–2) 0.1 (0.0–0.2) 2.2 (1.1–2)
A&E
  A&E visits, mean (SD, IQR) 1.7 (1.8–2) 0.1 (0.1–0.7) 0.5 (0.6–1)
Outpatient care
  Outpatient attendances, mean (SD, IQR) 5.1 (11.9–6) 0.4 (0.9–0.5) 0.5 (2.2–0)
Primary care contacts
  GP consultations, mean (SD, IQR) 19.8 (17.6–24) 1.6 (1.4–2) 2.8 (3.0–5)
  Out- of- hours, mean (SD, IQR) 0.8 (1.8–1) 0.1 (0.2–0.1) 0.2 (0.7–0)
  Telephone consultations, mean (SD, IQR) 2.1 (4.0–2) 0.2 (0.3–0.2) 0.4 (0.9–0)
  Home visits, mean (SD, IQR) 2.1 (4.6–2) 0.2 (0.4–0.2) 0.5 (1.1–0)
  Prescriptions, mean (SD, IQR) 84.9 (98.1–94) 7.0 (8.1–7.8) 7.8 (10.7–12)
A&E, Accident & Emergency; GP, general practitioner; ICU, intensive care unit; LOS, length of stay.
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0.88 to 0.95, p<0.0001 for age group 90+ compared 
with to the reference category 60–69) and were lower 
among females (0.91, 95% CI 0.90 to 0.92, p<0.0001 
compared with males).
Models for healthcare utilisation and costs reveal 
regional variation as shown in figure 4. For instance, 
costs in the last year of life were higher (1.09, 95% CI 
1.01 to 1.14, p<0.0001) in London compared with 
other regions. In the last months of life, costs were 
higher in Yorkshire and The Humber (1.17, 95% CI 
1.08 to 1.26, p<0.0001) and London (1.10, 95% CI 
1.03 to 1.18, p<0.002). The South- West has relatively 
low costs and hospitalisations compared with the 
other regions and has the highest number of primary 
care contacts.
DISCUSSION
Main findings
We assessed the intensity of services received in the last 
year of life using a large patient- level linked dataset 
covering primary care, outpatient and inpatient care. 
As previously documented,9 27 healthcare utilisation 
and costs in the last year of life increase with proximity 
to death, particularly in the last month of life. The 
main driver of healthcare intensity and costs is inpa-
tient hospital care, although we also observe a marked 
increase in A&E visits and primary care contacts in 
the last month of life. Our results suggest that health-
care utilisation and costs decrease with age at death, 
and are higher in men, patients dying from cancer 
and patients with high comorbidities. Analysis of 
regional variation, although based on a small number 
of large regions, reveals that hospital admissions and 
associated costs are higher in London, and that there 
might be some substitutability between primary care 
and inpatient care. We did not observe great variation 
in healthcare use and costs across IMD, contrary to 
previous evidence in patients with cancer.28
Strengths and limitations
The main strength of this study is that we exploit a 
rich patient- level dataset covering both primary and 
secondary care activity and related costs. The size of 
the dataset allowed us to study variation in health-
care use and cost trajectories by cause of death, IMD 
and region. Another strength is that it was conducted 
in tandem with a Scottish study thereby enabling 
comparisons between the two countries, both in terms 
Figure 3 General linear model: healthcare costs in the last 12 
months of life. COPD, chronic obstructive pulmonary disease; 
IMD, Index of Multiple Deprivation.
Figure 4 Models of healthcare utilisation and costs in the last 
12 months of life across regions.
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of end- of- life care trajectories and in terms of data 
availability. Specifically, both datasets differed in terms 
of breadth and depth. For instance, while our analysis 
relied on a sample of practices, the analysis in Scot-
land exploited data for the whole country and used 
measures of rurality that were not available in England. 
However, the Scottish data were more limited in scope 
as it did not include primary care activity. Overall, 
conducting the two studies with different datasets 
make common findings more robust, while allowing 
complementary insights into specific determinants.
We acknowledge several limitations to our study. As 
in all observational research, our study is subject to 
biases. Our analysis was restricted to CPRD general 
practices in England that participated to HES data 
linkage over the whole study period, that is, 2010–
2017. Participating practices may be different from 
the average practice. For instance, very low number 
of patients were observed in some regions (eg, North 
East), our data are, therefore, not necessarily represen-
tative at the region level. Conversely, South East Coast 
is over- represented compared with other regions. 
Several factors may potentially increase GP participa-
tion in primary care data collection including younger 
age, males, urban location and type of practice.29 30 
Another limitation is that despite having access to rich 
primary care and hospital level data, we were not able 
to assess utilisation and costs of health and social care 
in other settings. In particular, we were not able to 
identify use/needs of palliative care using our primary 
care data due to very low number of relevant codes 
indicating potential incomplete coding in this area.
We had no data related to living circumstances and 
either formal or informal social care support (eg, 
whether decedents lived in care homes or in their own 
homes with packages of care, whether they lived alone 
or had partners or family carers). Such services are 
likely to affect who needs hospital- based care towards 
the end of life. We did not have information on the 
availability, accessibility and use of palliative care 
services, hospice beds, or anticipatory care planning. 
While we were able to measure comorbidities, this was 
only captured in hospital data. Also, we did not have 
measures of patient frailty, which is well recognised as 
an important determinant of care requirements and 
risk of death. Finally, while we were able to measure 
activity and costs, the use of administrative data does 
not allow us to assess appropriateness of services used, 
and whether these align with patient preferences.
What this study adds
Our results are in line with previous U.K studies on 
healthcare use and costs in the last year of life that 
found high costs and inpatient activity in the last year 
of life and that highlighted the role of proximity to 
death, age at death and comorbidity.9 27 31–34 Our find-
ings are in line with measures of hospital use reported 
in a study comparing outcomes in seven countries.34 
Our main contribution is the analysis of both costs and 
healthcare use, including primary care, for all dece-
dents, when previous studies often focused on inpa-
tient care and/or patients with cancer. We have shown 
that it is not only the condition that is the direct cause 
of death, but also the comorbidities individuals have, 
which impact their healthcare usage. Secondary care 
is often led by a single specialty (eg, oncology) and 
this may come at the expense of a more holistic view. 
Models of supportive care that attend to the spec-
trum of conditions that people may be living with/
dying from are needed. Less intensive and aggressive, 
end- of- life care potentially community- based, may be 
desirable for most individuals, and may lead to systems 
cost savings. However, if optimum patient care is to 
be provided, such a shift away from secondary care 
should be accompanied by investments in alterna-
tive care arrangements such as enhanced community 
palliative care provision and support for families 
and carers. Advance care planning (ACP) discussions 
and records can usefully inform transitions in care 
between acute hospitals and the community, particu-
larly with regard to realistic goals of care. Given the 
scale of hospital admissions and discharges demon-
strated in our study, increasing the uptake and quality 
of ACP is recommended. We are currently examining 
experiences of ACP conversations and their perceived 
value in an interview- based study of bereaved family 
members.
Future research
Future research should include more information on 
the social situation of decedents, including place of 
residence and whether carers are supporting at home. 
Also, finer geographical data and more information 
on healthcare supply and organisation would allow 
further investigating whether people receiving more 
planned care by primary care and or specialist pallia-
tive care towards the end of life require less acute care. 
Also, place of death as a key outcome in end- of- life 
care was not available at time of data extraction and 
we plan to complement the analysis by focusing on 
place of death as an outcome.
Overall, several questions remain unanswered 
when relying essentially on administrative data, that 
is, how are decisions made about the right kind of 
care by clinicians? What needs drive acute hospital 
care at the end of life? To what extent is availability 
of alternative options to hospital important? What is 
the value of primary care and hospital- based care for 
people living with advanced illness? Such ‘Big Data’ 
analysis should, therefore, be complemented by qual-
itative work. The findings from this study provide a 
foundation for qualitative work, which is essential to 
understand the lived experience of service users and 
those close to them, but also views of clinicians and 
policy- makers.
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CONCLUSION
Primary and secondary care use and associated costs 
increase sharply in the last year of life in England, and 
there is heterogeneity in care trajectories by cause of 
death and region of residence. Further quantitative 
and qualitative work is needed to better understand 
drivers of the variation described in this study.
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